| Authors: |
Roques P; Université Paris-Saclay, INSERM, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses, France., Fritzer A; Valneva Austria GmbH, Campus Vienna Biocenter 3, Vienna, Austria., Dereuddre-Bosquet N; Université Paris-Saclay, INSERM, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses, France., Wressnigg N; Valneva Austria GmbH, Campus Vienna Biocenter 3, Vienna, Austria., Hochreiter R; Valneva Austria GmbH, Campus Vienna Biocenter 3, Vienna, Austria., Bossevot L; Université Paris-Saclay, INSERM, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses, France., Pascal Q; Université Paris-Saclay, INSERM, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses, France., Guehenneux F; Valneva SE, Saint Herblain, France., Bitzer A; Valneva Austria GmbH, Campus Vienna Biocenter 3, Vienna, Austria., Corbic Ramljak I; Valneva Austria GmbH, Campus Vienna Biocenter 3, Vienna, Austria., Le Grand R; Université Paris-Saclay, INSERM, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses, France., Lundberg U; Valneva Austria GmbH, Campus Vienna Biocenter 3, Vienna, Austria., Meinke A; Valneva Austria GmbH, Campus Vienna Biocenter 3, Vienna, Austria. |